Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Colorcon
Baxter
Chubb
Boehringer Ingelheim
US Army
Federal Trade Commission
QuintilesIMS
Accenture
Deloitte

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020911

« Back to Dashboard

NDA 020911 describes QVAR 80, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from five suppliers. There are two patents protecting this drug. Additional details are available on the QVAR 80 profile page.

The generic ingredient in QVAR 80 is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.
Summary for 020911
Tradename:QVAR 80
Applicant:Teva Branded Pharm
Ingredient:beclomethasone dipropionate
Patents:2
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020911
Suppliers and Packaging for NDA: 020911
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911 NDA A-S Medication Solutions 50090-1342 N 50090-1342-0
QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911 NDA RPK Pharmaceuticals, Inc. 53002-1436 N 53002-1436-2

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.08MG/INH
Approval Date:Sep 15, 2000TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, METERED;INHALATIONStrength0.04MG/INH
Approval Date:Sep 15, 2000TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 020911

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm QVAR 80 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-001 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 80 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-001 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 80 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-001 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 40 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-002 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm QVAR 80 beclomethasone dipropionate AEROSOL, METERED;INHALATION 020911-001 Sep 15, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Harvard Business School
Merck
Teva
Boehringer Ingelheim
US Department of Justice
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot